Not a good buy right now for an impatient trader: price is breaking down into/through support with bearish momentum still expanding.
Better setup would be a reclaim of ~$12.15 (S1) and especially the ~$12.94 pivot before getting aggressive; until then, downside chop risk is higher than immediate upside.
Medium-term upside case exists (street targets $13–$16, hedge fund buying, synergy narrative), but the near-term tape argues for waiting rather than buying today.
Technical Analysis
Trend/momentum: MACD histogram is negative (-0.164) and negatively expanding → bearish momentum increasing.
RSI(6) at 28.91 → stretched/oversold conditions are developing, but oversold can persist during downtrends.
Moving averages are converging → no clear trend support from MAs; price action is the key.
Levels: S1 ~$12.15 and S2 ~$11.66; current ~$11.64 is essentially at/just below S2 → support is being tested/violated, which is weak for immediate entries.
Resistance overhead: pivot ~$12.94 then R1 ~$13.73; reclaiming these would improve the risk/reward for longs.
Pattern-based projection: similar-pattern stats imply ~-1.53% next day, ~-1.31% next week, but +9.84% next month → near-term pressure with potential rebound later.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment skew: Put/Call OI ratio 0.66 and Put/Call volume ratio 0.09 → call-heavy positioning/flow, generally bullish.
Activity: today’s option volume vs 30D avg is very elevated (~20.77x) → heightened event/speculation interest.
Volatility: 30D IV ~58.16 vs historical vol ~44.43 → options pricing implies elevated expected moves.
IV positioning: IV percentile ~37.6 / IV rank ~16 → not extreme vs its own history, but still elevated in absolute terms.
Technical Summary
Sell
4
Buy
8
Positive Catalysts
Analyst tone has improved materially (multiple Buys/Overweights; targets generally $13–$16), reinforcing a medium-term upside narrative.
Strategic M&A narrative (Anywhere-related synergy/deleveraging commentary in analyst notes) remains a potential re-rating driver.
Hedge fund activity: reported buying increased ~193% last quarter → supportive institutional demand.
Upcoming earnings (QDEC 2025 on 2026-02-17 pre-market) can act as a catalyst for a rebound if results/guide surprise positively.
Insider/politician/congress: insiders neutral (no significant recent trend); no recent congress trading data; no influential-figure transactions provided.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: clear wave of upgrades/initiations and higher price targets from late 2025 into Jan 2026.
Key actions: Deutsche Bank upgraded to Buy with PT raised to $16 (from $9); JPMorgan initiated Overweight with $15; BTIG kept Buy and raised PT to $15; Barclays upgraded to Overweight with $13; Goldman reinstated Neutral with $14.
Wall Street pros: synergy/deleveraging path from transformative acquisitions; unified tech platform; margin inflection potential.
Wall Street cons: limited visibility tied to housing affordability and recovery uncertainty; concern that broader/non-premium exposure may slow historical market-share gains pace.
Wall Street analysts forecast COMP stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for COMP is 11.25 USD with a low forecast of 8 USD and a high forecast of 13 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast COMP stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for COMP is 11.25 USD with a low forecast of 8 USD and a high forecast of 13 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
1 Hold
0 Sell
Strong Buy
Current: 12.040
Low
8
Averages
11.25
High
13
Current: 12.040
Low
8
Averages
11.25
High
13
Goldman Sachs
Neutral
initiated
$14
AI Analysis
2026-01-27
Reason
Goldman Sachs
Price Target
$14
AI Analysis
2026-01-27
initiated
Neutral
Reason
Goldman Sachs reinstated coverage of Compass with a Neutral rating and $14 price target, which implies 5% upside, following the Anywhere Real Estate acquisition. The firm sees limited visibility for Compass, saying the housing recovery facing ongoing affordability challenges. The company has growing exposure to non-premium segments of the housing market through its merger with Anywhere, which could make it more challenging for the new Compass to achieve its historical pace of market share gains, the analyst tells investors in a research note.
JPMorgan
initiated
$15
2026-01-26
Reason
JPMorgan
Price Target
$15
2026-01-26
initiated
Reason
JPMorgan initiated coverage of Compass with an Overweight rating and $15 price target. The firm says the company's "transformational" acquisitions, "unified" technology platform, and accelerating margin inflection position it as the premier consolidator in U.S. residential real estate. The Anywhere merger unlocks $300M in targeted synergies, recurring high-margin revenue, and a clear path to deleveraging, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for COMP
